Browse views: by Year, by Function, by GLF, by Subfunction, by Conference, by Journal

Identification of coumarin derivatives as a novel class of allosteric MEK1 inhibitors.

Han, Shulin and Zhou, Vicki and Pan, Shifeng and Liu, Yi and Hornsby, Michael and Mcmullan, Daniel and Klock, Heath and Haugen, Justin and Lesley, Scott and Gray, Nathanael and Caldwell, Jeremy and Gu, Xiang-Ju (2005) Identification of coumarin derivatives as a novel class of allosteric MEK1 inhibitors. Bioorganic & Medicinal Chemistry Letters, 15 (24). pp. 5467-5473. ISSN 0960-894X

Abstract

A homogenous TR-FRET-based in vitro coupling assay for the MAP3Ks-MEK1-ERK2 kinase cascade was established and was used to screen for inhibitors of the ERK/MAPK pathway. A series of coumarin derivatives were identified from the screen. These compounds potently inhibit the activation of the unactivated human MEK1 by upstream MAP3Ks (including BRAF and COT), but do not inhibit the activity of the activated MEK1. In addition, the potency of these compounds in inhibiting MEK1 activation is not affected by varying the ATP concentration, suggesting that these inhibitors are not competitive with ATP. As expected, the coumarin compounds potently inhibit LPS-induced TNFalpha production and ERK phosphorylation in THP-1 cells, with the most potent compound having an IC(50) of 90nM. Molecular modeling studies suggest that these coumarins bind to an allosteric site in the inactive conformation of MEK1. This site has been shown to be utilized by the biarylamine series of MEK inhibitors such as PD318088. Very interestingly, the identified coumarin derivatives are almost identical to a series of inhibitors recently reported that block LPS-induced TNFalpha production. Our findings have therefore raised the possibility that other naturally occurring or synthetic coumarins with anti-cancer and anti-inflammatory activities might exert their biological function through the inhibition of MEK1.

Item Type: Article
Related URLs:
Additional Information: author can archive post-print (ie final draft post-refereeing); Publisher's version/PDF cannot be used
Keywords: MEK1; Coumarins; Allosteric Inhibitors; TR-FRET; COT; RAF
Related URLs:
Date Deposited: 14 Dec 2009 14:02
Last Modified: 31 Jan 2013 01:23
URI: https://oak.novartis.com/id/eprint/243

Search

Email Alerts

Register with OAK to receive email alerts for saved searches.